Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trigonal-sparing vs Trigonal-involved Botox in Refractory OAB
NCT03533062Completed
- Sponsor
- Mansoura University
- Start
- Jun 2015
- Primary completion
- Oct 2016
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Randomised trial of botulinum toxin type A in overactive bladder syndrome (OAB) (2 arms), sponsored by Mansoura University. Primary endpoint: Over Active Bladder Symptoms Score at 3 months. Started Jun 2015; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
overactive bladder syndrome (OAB)
Beyond the preview
Go deeper on NCT03533062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03533062.